PHMMF (Pharma Mar) Long-Term Debt : $41.7 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Pharma Mar Long-Term Debt?

Pharma Mar's Long-Term Debt for the quarter that ended in Dec. 2024 was $41.7 Mil.

Pharma Mar's quarterly Long-Term Debt increased from Jun. 2024 ($28.0 Mil) to Sep. 2024 ($28.8 Mil) and increased from Sep. 2024 ($28.8 Mil) to Dec. 2024 ($41.7 Mil).

Pharma Mar's annual Long-Term Debt increased from Dec. 2022 ($27.4 Mil) to Dec. 2023 ($29.5 Mil) and increased from Dec. 2023 ($29.5 Mil) to Dec. 2024 ($41.7 Mil).

Pharma Mar Long-Term Debt Historical Data

The historical data trend for Pharma Mar's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Long-Term Debt Chart

Pharma Mar Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

45.90

37.72

27.42

29.48

41.74

Pharma Mar Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															29.48	28.14	28.02	28.83	41.74

Pharma Mar (OTCPK:PHMMF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pharma Mar Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (OTCPK:PHMMF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

PHMe:UK 0RC6:UK PHM:Spain PMRA:Germany PHM:Austria

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.